Template:Pico of the day/2014-07-31

From Wiki Journal Club
Jump to navigation Jump to search
Clinical question of the day
Among patients with advanced indolent lymphomas, how does first-line therapy with rituximab-bendamustine (B-R) compare to rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone (R-CHOP) in terms of progression-free survival (PFS), overall survival (OS), and toxicity profile?
– StiL
Retrieved from "http://www.wikijournalclub.org/w/index.php?title=Template:Pico_of_the_day/2014-07-31&oldid=13486"